These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10139487)

  • 21. A systematic review on current status of health technology reassessment: insights for South Korea.
    Seo HJ; Park JJ; Lee SH
    Health Res Policy Syst; 2016 Nov; 14(1):82. PubMed ID: 27835964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health technology assessment: decentralized and fragmented in the US compared to other countries.
    Perry S; Thamer M
    Health Policy; 1997 Jun; 40(3):177-98. PubMed ID: 10168751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is more neonatal intensive care always better? Insights from a cross-national comparison of reproductive care.
    Thompson LA; Goodman DC; Little GA
    Pediatrics; 2002 Jun; 109(6):1036-43. PubMed ID: 12042540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies for technology assessment and implementation in some European countries.
    Stocking B
    Int J Technol Assess Health Care; 1986; 2(1):19-26. PubMed ID: 10276247
    [No Abstract]   [Full Text] [Related]  

  • 25. Public engagement in health technology assessment and coverage decisions: a study of experiences in France, Germany, and the United Kingdom.
    Kreis J; Schmidt H
    J Health Polit Policy Law; 2013 Feb; 38(1):89-122. PubMed ID: 23052686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health technology assessment: a sociological commentary on reflexive innovation.
    Webster A
    Int J Technol Assess Health Care; 2004; 20(1):61-6. PubMed ID: 15176178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care technology in the United Kingdom.
    Spiby J
    Health Policy; 1994; 30(1-3):295-334. PubMed ID: 10139494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22619775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22582452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The place of magnetic resonance imaging in health care.
    Hailey D; Marshall D
    Health Policy; 1995 Jan; 31(1):43-52. PubMed ID: 10140362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health care technology in the Federal Republic of Germany.
    Kirchberger S
    Health Policy; 1994; 30(1-3):163-205. PubMed ID: 10139490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.
    Manchikanti L; Falco FJ; Boswell MV; Hirsch JA
    Pain Physician; 2010; 13(1):E23-54. PubMed ID: 20119474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Socioeconomic inequalities in waiting times for primary care across ten OECD countries.
    Martin S; Siciliani L; Smith P
    Soc Sci Med; 2020 Oct; 263():113230. PubMed ID: 32823046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social construction of disability and substance abuse within public disability benefit systems.
    Brucker DL
    Int J Drug Policy; 2009 Sep; 20(5):418-23. PubMed ID: 18977648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain.
    Ray JA; Valentine WJ; Secnik K; Oglesby AK; Cordony A; Gordois A; Davey P; Palmer AJ
    Curr Med Res Opin; 2005 Oct; 21(10):1617-29. PubMed ID: 16238902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Conception and conversion of medical technology assessment--an international comparison].
    Berndt K; Hinzpeter B; Kurscheid T; Lauterbach KW
    Z Arztl Fortbild Qualitatssich; 1998 May; 92(4):255-62. PubMed ID: 9675828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and Austria.
    Wild C; Gibis B
    Health Policy; 2003 Feb; 63(2):187-96. PubMed ID: 12543531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Policy implications of the diffusion and control of medical technology.
    Banta HD; Burns AK; Behney CJ
    Ann Am Acad Pol Soc Sci; 1983 Jul; (468):165-81. PubMed ID: 10299096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reflections on the evolution of health technology assessment in Europe.
    Sorenson C; Chalkidou K
    Health Econ Policy Law; 2012 Jan; 7(1):25-45. PubMed ID: 22221927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study of nursing systems in transition in developed countries].
    Kojima M; Horiuchi S; Ota K; Oikawa I; Kaharu C; Nomura M; Toyomasu K; Hatono Y; Kanda K; Tanaka Y
    Seiroka Kango Daigaku Kiyo; 1997; 23():49-68. PubMed ID: 9444242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.